{
  "id": 16739564,
  "title": "Novartis considers bypassing European government payers due to MFN",
  "url": "https://urgent.news/2026/10/27/novartis-considers-bypassing-european-government-payers-due-to-mfn",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-27T10:34:44.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/novartis-considers-bypassing-european-government-payers-due-to-mfn/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novartis CEO Vas Narasimhan said Tuesday that launching new drugs in the private market or in a self-pay market in Europe is not off the table in response to the so-called most favored nation policy. ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}